Martingale Asset Management L P Vanda Pharmaceuticals Inc. Transaction History

Martingale Asset Management L P

  • $4.27 Billion
  • Q3 2024

A detailed history of Martingale Asset Management L P transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 70,009 shares of VNDA stock, worth $324,141. This represents 0.01% of its overall portfolio holdings.

Number of Shares
70,009
Previous 75,515 7.29%
Holding current value
$324,141
Previous $426,000 23.0%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$4.61 - $6.34 $25,382 - $34,908
-5,506 Reduced 7.29%
70,009 $328,000
Q1 2024

May 14, 2024
BUY
$3.47 - $4.61 $10,448 - $13,880
3,011 Added 4.15%
75,515 $310,000
Q4 2023

Feb 12, 2024
SELL
$3.38 - $4.58 $26,086 - $35,348
-7,718 Reduced 9.62%
72,504 $305,000
Q3 2023

Nov 14, 2023
BUY
$4.28 - $6.57 $56,710 - $87,052
13,250 Added 19.78%
80,222 $346,000
Q2 2023

Aug 11, 2023
BUY
$5.9 - $6.95 $107,987 - $127,205
18,303 Added 37.61%
66,972 $441,000
Q1 2023

May 12, 2023
SELL
$6.18 - $7.99 $188,465 - $243,663
-30,496 Reduced 38.52%
48,669 $330,000
Q4 2022

Feb 13, 2023
BUY
$6.87 - $10.96 $17,312 - $27,619
2,520 Added 3.29%
79,165 $585,000
Q3 2022

Nov 14, 2022
BUY
$9.44 - $11.76 $492,078 - $613,013
52,127 Added 212.61%
76,645 $758,000
Q2 2022

Aug 11, 2022
SELL
$9.31 - $11.84 $50,274 - $63,936
-5,400 Reduced 18.05%
24,518 $267,000
Q1 2022

May 12, 2022
SELL
$10.84 - $16.55 $504,255 - $769,872
-46,518 Reduced 60.86%
29,918 $338,000
Q4 2021

Feb 11, 2022
SELL
$15.69 - $21.14 $54,915 - $73,990
-3,500 Reduced 4.38%
76,436 $1.2 Million
Q3 2021

Nov 12, 2021
BUY
$15.35 - $21.27 $210,295 - $291,399
13,700 Added 20.68%
79,936 $1.37 Million
Q2 2021

Aug 13, 2021
SELL
$15.71 - $21.51 $29,849 - $40,869
-1,900 Reduced 2.79%
66,236 $1.42 Million
Q1 2021

May 13, 2021
BUY
$13.42 - $20.28 $79,298 - $119,834
5,909 Added 9.5%
68,136 $1.02 Million
Q4 2020

Feb 10, 2021
BUY
$9.77 - $13.81 $70,373 - $99,473
7,203 Added 13.09%
62,227 $817,000
Q3 2020

Nov 12, 2020
SELL
$9.32 - $12.02 $414,740 - $534,890
-44,500 Reduced 44.71%
55,024 $531,000
Q2 2020

Aug 10, 2020
BUY
$9.66 - $12.02 $961,401 - $1.2 Million
99,524 New
99,524 $1.14 Million

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $262M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email